Clinical Trial Update: Effects of VALsartan On atRIAl Mitral Regurgitation: A Pilot Randomized Controlled Trial [Phase 2, Phase 3]

View source ↗

Summary

An update on a pilot randomized controlled trial evaluating valsartan for atrial functional mitral regurgitation; the study is phase 2/3 and not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Functional Mitral Regurgitation

Drugs mentioned

• VALSARTAN (Valsartan)

Snippet

Sponsor: Jonathan Beaudoin | Conditions: Atrial Functional Mitral Regurgitation | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING